MARIOTTINI, ALICE

MARIOTTINI, ALICE  

Neuroscienze, Area del Farmaco e Salute del Bambino (NEUROFARBA)  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance In corso di stampa Mariottini A, Repice AM, Barilaro A, Massacesi L
Antibody-mediated cell depletion therapies in multiple sclerosis 2022 Mariottini, Alice; Muraro, Paolo A; Lünemann, Jan D
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series 2021 Nicholas R.S.; Rhone E.E.; Mariottini A.; Silber E.; Malik O.; Singh-Curry V.; Turner B.; Scalfari A.; Ciccarelli O.; Sormani M.P.; Olavarria E.; Mehra V.; Gabriel I.; Kazmi M.A.; Muraro P.
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 2021 Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 2013 Galante, A; Bonechi, E; Mariottini, A; Aldinucci, A; Biagioli, T; Mechi, C; Repice, A; Massacesi, L; Ballerini, C
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
COVID-19 in patients with aggressive MS treated with aHSCT: a multi-center study 2021 E. Sbragia, A. Mariottini, M. Capobianco, S. Martire, L. Moiola, M.P. Amato, L. Massacesi, G. Mancardi, G. Boffa, M. Inglese
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 2017 Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A.
Early Morbidity of Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis- A Real World Experience 2021 Varun Mehra, Maria Cuadrado, Elijah Rhone, Alice Mariottini, Victoria Williams, Sarah Ware, Paolo Muraro, Antonio Pagliuca, Victoria Potter, Eli Silber, Majid Kazmi
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis In corso di stampa Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C,Barilaro A,Massacesi L,Repice A.
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status 2020 Mariottini, Alice; De Matteis, Eleonora; Muraro, Paolo A.
Immunosenescence and Autoimmunity: Exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis 2021 Amoriello, Roberta; Mariottini, Alice; Ballerini, Clara
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 2021 Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M.
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 2021 A Mariottini, C Innocenti, G Rastrelli, L Vignozzi, A Giachi, R Saccardi, L Massacesi, A Repice
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 2016 Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 2022 Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Luca Massacesi, Paolo Francesconi